Method for producing pyrrolidine compound
US-2026042733-A1 · Feb 12, 2026 · US
This page is not indexed by search engines while we improve data quality.
Takeda Pharmaceuticals Co — Cross-Sectional Technologies
Takeda Pharmaceuticals Co holds 40 patents in Cross-Sectional Technologies, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Takeda Pharmaceuticals Co |
| Technology | Cross-Sectional Technologies |
| Patents in slice | 40 |
| Recent patents in slice | 10 |
| First year | 2016 |
| Last year | 2026 |
Representative patents
Notable publications linking Takeda Pharmaceuticals Co to Cross-Sectional Technologies.
Method for producing enteric neural precursors
US-12516288-B2 · Jan 6, 2026 · US
Method for producing pyrrolidine compound
US-12479798-B2 · Nov 25, 2025 · US
Stabilized liquid and lyophilized adamts13 formulations
US-2025099559-A1 · Mar 27, 2025 · US
Stabilized liquid and lyophilized ADAMTS13 formulations
US-12178861-B2 · Dec 31, 2024 · US
Recent filings
Latest patents from Takeda Pharmaceuticals Co in Cross-Sectional Technologies.
Method for producing pyrrolidine compound
US-2026042733-A1 · Feb 12, 2026 · US
Method for producing enteric neural precursors
US-12516288-B2 · Jan 6, 2026 · US
Method for producing pyrrolidine compound
US-12479798-B2 · Nov 25, 2025 · US
Stabilized liquid and lyophilized adamts13 formulations
US-2025099559-A1 · Mar 27, 2025 · US
Stabilized liquid and lyophilized ADAMTS13 formulations
US-12178861-B2 · Dec 31, 2024 · US
Related pages
Navigate to parent entity pages.